124 related articles for article (PubMed ID: 8432982)
1. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
[TBL] [Abstract][Full Text] [Related]
2. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
Sant AJ
J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
[TBL] [Abstract][Full Text] [Related]
3. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
4. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
[TBL] [Abstract][Full Text] [Related]
5. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.
Cammarota G; Scheirle A; Takacs B; Doran DM; Knorr R; Bannwarth W; Guardiola J; Sinigaglia F
Nature; 1992 Apr; 356(6372):799-801. PubMed ID: 1574119
[TBL] [Abstract][Full Text] [Related]
6. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
7. A site for CD4 binding in the beta 1 domain of the MHC class II protein HLA-DR1.
Brogdon J; Eckels DD; Davies C; White S; Doyle C
J Immunol; 1998 Nov; 161(10):5472-80. PubMed ID: 9820523
[TBL] [Abstract][Full Text] [Related]
8. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
9. Regulation of T helper-B lymphocyte adhesion through CD4-HLA class II interaction.
Mazerolles F; Amblard F; Lumbroso C; Lecomte O; Van de Moortele PF; Barbat C; Piatier-Tonneau D; Auffray C; Fischer A
Eur J Immunol; 1990 Mar; 20(3):637-44. PubMed ID: 1969350
[TBL] [Abstract][Full Text] [Related]
10. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8.
König R; Huang LY; Germain RN
Nature; 1992 Apr; 356(6372):796-8. PubMed ID: 1574118
[TBL] [Abstract][Full Text] [Related]
11. Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling.
Harton JA; Bishop GA
J Immunol; 1993 Nov; 151(10):5282-9. PubMed ID: 8228224
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous involvement of all six predicted antigen binding loops of the T cell receptor in recognition of the MHC/antigenic peptide complex.
Kasibhatla S; Nalefski EA; Rao A
J Immunol; 1993 Sep; 151(6):3140-51. PubMed ID: 8376771
[TBL] [Abstract][Full Text] [Related]
13. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
[TBL] [Abstract][Full Text] [Related]
14. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution.
Braunstein NS; Germain RN; Loney K; Berkowitz N
J Immunol; 1990 Sep; 145(6):1635-45. PubMed ID: 1697304
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
Riberdy JM; Newcomb JR; Surman MJ; Barbosa JA; Cresswell P
Nature; 1992 Dec; 360(6403):474-7. PubMed ID: 1448172
[TBL] [Abstract][Full Text] [Related]
16. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
Vasmatzis G; Cornette J; Sezerman U; DeLisi C
J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
[TBL] [Abstract][Full Text] [Related]
17. Peptides corresponding to the CD8 and CD4 binding domains of HLA molecules block T lymphocyte immune responses in vitro.
Clayberger C; Lyu SC; DeKruyff R; Parham P; Krensky AM
J Immunol; 1994 Aug; 153(3):946-51. PubMed ID: 8027565
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
19. In vivo dimeric association of class I MHC heavy chains. Possible relationship to class I MHC heavy chain-beta 2-microglobulin dissociation.
Capps GG; Robinson BE; Lewis KD; Zúñiga MC
J Immunol; 1993 Jul; 151(1):159-69. PubMed ID: 8326123
[TBL] [Abstract][Full Text] [Related]
20. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
